Mumps Vaccine, Live (Zhejiang Vacin Biomedicine)

腮腺炎减毒活疫苗（艾美卫信生物药业）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMumps Vaccine, Live (Zhejiang Vacin Biomedicine)

Drug Alias NameN/A

ClassificationVaccines > Development/production technology > Live attenuated vaccineVaccines > National Immunization Program > Non-immunization program vaccine(Class II)Vaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsParotitis

Global Approved IndicationsParotitis

Approved Indications in ChinaParotitis

Original Approved Country/TerritoryMainland China

Original Approved Date1998/01/01

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaApproved

Originator CompaniesAimei Weixin BioPharm (Zhejiang) Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesAimei Weixin BioPharm (Zhejiang) Co Ltd

Inactive CompaniesN/A

Active IndicationsParotitis

Inactive IndicationsN/A

Other Information

ATC CodeJ07BE01